F.D.A. Strengthens Warnings on Lariam, an Anti-Malaria Drug

Tuesday, July 30, 2013 - 09:40 in Health & Medicine

The Food and Drug Administration said an anti-malaria drug, known as Lariam, must update its warning label to show that some of its psychiatric side effects can become permanent.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net